Bora Pharmaceuticals Co. Ltd (BORAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 155,447 | 160,525 | 158,203 | 136,179 | 178,276 |
| Cost of Goods | 98,977 | 87,985 | 92,573 | 78,739 | 120,323 |
| Gross Profit | 56,471 | 72,541 | 65,630 | 57,441 | 57,953 |
| Operating Expenses | 40,210 | 38,015 | 33,942 | 37,466 | 42,124 |
| Operating Income | 17,238 | 35,510 | 32,261 | 20,714 | 16,151 |
| Interest Expense | 3,912 | 4,179 | 3,793 | 3,672 | 3,806 |
| Other Income | 16,409 | -1,424 | -10,418 | 74,687 | 10,553 |
| Pre-tax Income | 29,734 | 29,907 | 18,050 | 91,729 | 22,898 |
| Income Tax | 12,575 | 2,462 | 3,495 | 8,107 | 3,465 |
| Net Income Continuous | 17,159 | 27,445 | 14,556 | 83,622 | 19,433 |
| Net Income Discontinuous | -4,126 | -6,170 | 6,086 | -40,795 | N/A |
| Minority Interests | 1,076 | 113 | 600 | 289 | 757 |
| Net Income | $11,958 | $21,163 | $20,042 | $42,538 | $18,676 |
| EPS Basic Total Ops | 0.00 | 0.03 | 0.04 | 0.08 | 0.04 |
| EPS Basic Continuous Ops | -0.01 | 0.04 | 0.03 | 0.16 | 0.04 |
| EPS Basic Discontinuous Ops | 0.01 | -0.01 | 0.01 | -0.08 | N/A |
| EPS Diluted Total Ops | 0.00 | 0.03 | 0.04 | 0.08 | 0.02 |
| EPS Diluted Continuous Ops | -0.01 | 0.04 | 0.03 | 0.15 | 0.02 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.01 | 0.01 | -0.07 | N/A |
| EBITDA(a) | $24,746 | $44,763 | $41,466 | $29,627 | $26,408 |